Cout dupixent usa sanofi?

Who makes Dupixent in the US?

Dupixent (dupilumab) is made by Regeneron Pharmaceuticals and its partner Sanofi. In the US market, the product is widely associated with both companies rather than one alone.

What is Sanofi’s role with Dupixent?

Sanofi and Regeneron share development and commercialization responsibilities for Dupixent. The US branding and supply relationships reflect that partnership, with Sanofi tied to the commercial rollout alongside Regeneron.

Does Dupixent come from Sanofi in the same way other Sanofi drugs do?

Dupixent is not a “Sanofi-only” biologic. It is a partnered product, so ownership, manufacturing responsibility, and commercial rights are shared across the two companies under their agreement structure.

Sources

• [1] https://www.drugpatentwatch.com/